Literature DB >> 15122606

Outcome of abdominal aortic aneurysm repair in the era of endovascular treatment.

C J Zeebregts1, R H Geelkerken, J van der Palen, A B Huisman, P de Smit, R J van Det.   

Abstract

BACKGROUND: The effect on outcome of the introduction of endovascular techniques for the exclusion of abdominal aortic aneurysm (AAA) is largely unknown. The aim of the study was to contrast the early and mid-term outcome after open and endovascular AAA repair.
METHODS: Consecutive patients who underwent transfemoral endovascular aneurysm repair (EVAR; n = 93) between April 1998 and January 2003, or conventional open aneurysm repair in the time intervals before (n = 113) and after (n = 82) the introduction of EVAR were studied. All data were collected prospectively. All patients underwent elective and primary repair. Patient survival was calculated by the Kaplan-Meier method and the possible predictive value of more than 25 perioperative variables on five outcome variables (length of intensive care unit stay, morbidity, and 30-day, 6-month and overall mortality) was assessed by multivariate analysis.
RESULTS: There were no differences in risk profiles between the three groups. Selection for EVAR was based on anatomical grounds only. All five outcome variables were significantly better with EVAR than either former or recent open repair. The only significant predictors of failure were advanced age and the need to perform an additional procedure for former open repair; hypertension and the preoperative use of anticoagulants for recent open repair; and renal insufficiency and pulmonary insufficiency for EVAR.
CONCLUSION: EVAR offered considerable benefits compared with conventional open repair at early and mid-term follow-up, which was not explained by selection of patients with a favourable risk profile. In the current era, in which patients are selected for open repair as a consequence of unfavourable anatomy, morbidity and mortality rates following conventional open treatment of AAA have increased at early and mid-term, but not at long-term, follow-up. Copyright 2004 British Journal of Surgery Society Ltd.

Entities:  

Mesh:

Year:  2004        PMID: 15122606     DOI: 10.1002/bjs.4529

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  6 in total

1.  Changes in laboratory values and their relationship with time after rupture of an abdominal aortic aneurysm.

Authors:  Jan W Haveman; Clark J Zeebregts; Eric L G Verhoeven; P van den Berg; Jan J A M van den Dungen; Jan H Zwaveling; Maarten W N Nijsten
Journal:  Surg Today       Date:  2008-11-28       Impact factor: 2.549

2.  Open treatment versus endovascular repair for aortic abdominal aneurysm-keeping the balance.

Authors:  Wtgj Bos; T Cohen; G Vourliotakis; Mrhm van Sambeek; Elg Verhoeven
Journal:  Ann Vasc Dis       Date:  2009-12-14

Review 3.  Endovascular abdominal aortic aneurysm repair.

Authors:  M G A Norwood; G M Lloyd; M J Bown; G Fishwick; N J London; R D Sayers
Journal:  Postgrad Med J       Date:  2007-01       Impact factor: 2.401

4.  Risk factors for early renal dysfunction following endovascular aortic aneurysm repair and its effect on the postoperative outcome.

Authors:  Naoki Toya; Takao Ohki; Yasutake Momokawa; Kota Shukuzawa; Soichiro Fukushima; Hiromasa Tachihara; Tadashi Akiba
Journal:  Surg Today       Date:  2016-03-19       Impact factor: 2.549

Review 5.  Effects of study design and trends for EVAR versus OSR.

Authors:  Robert Hopkins; James Bowen; Kaitryn Campbell; Gord Blackhouse; Guy De Rose; Teresa Novick; Daria O'Reilly; Ron Goeree; Jean-Eric Tarride
Journal:  Vasc Health Risk Manag       Date:  2008

Review 6.  Open versus Endovascular Repair of Abdominal Aortic Aneurysm in the Elective and Emergent Setting in a Pooled Population of 37,781 Patients: A Systematic Review and Meta-Analysis.

Authors:  Dustin M Thomas; Edward A Hulten; Shane T Ellis; David M F Anderson; Nathan Anderson; Fiora McRae; Jamil A Malik; Todd C Villines; Ahmad M Slim
Journal:  ISRN Cardiol       Date:  2014-04-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.